Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 26Recruiting 10Active not recruiting 10Terminated 6Withdrawn 2Unknown 2No longer available 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 8Genitourinary 2CNS 2Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 240Carcinoma, Renal Cell 75Urinary Bladder Neoplasms 56Kidney Neoplasms 32Breast Neoplasms 26Neoplasms 25Carcinoma, Transitional Cell 22Neoplasm Metastasis 21Carcinoma, Non-Small-Cell Lung 14Sarcoma 11Non-Muscle Invasive Bladder Neoplasms 11Lung Neoplasms 11Melanoma 10Wilms Tumor 8Testicular Neoplasms 8Colorectal Neoplasms 8Uterine Cervical Neoplasms 7Urologic Neoplasms 7Stomach Neoplasms 7Pancreatic Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Recurrence 6Ovarian Neoplasms 6Endometrial Neoplasms 6Carcinoma, Hepatocellular 6Carcinoma 6Prostatic Neoplasms, Castration-Resistant 5Neuroblastoma 5Esophageal Neoplasms 5

Interventions

Temozolomide 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Sarcoma, Ewing × Genitourinary × Clear all
NCT04791228 2025-01-01

A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors

Children's National Research Institute

Phase 2 Withdrawn
GastrointestinalGenitourinarySarcoma

Carcinoma, Carcinoma, Hepatocellular, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Recurrence, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing

NCT02689336 2019-09-09

Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors

Washington University School of Medicine

Phase 2 Withdrawn
CNSGenitourinarySarcoma

Ependymoma, Glioma, Medulloblastoma, Wilms Tumor, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡